-

ixlayer Appoints Bernard Esquivel, MD, PhD, as Head of Clinical Innovation

Industry veteran to bolster company’s diagnostic lab services expansion across health plans, retail, providers, biopharma and government

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announces Bernard Esquivel, MD, PhD, as the Head of Clinical Innovation. Esquivel will play an instrumental role in shaping the company's health testing strategy, including its continued expansion into the labs and diagnostics space.

“With demand for more convenient and accessible lab testing growing among health plans, retailers and providers -- so they may better support the patients they serve -- forward-thinking healthcare organizations need an end-to-end platform to power better health testing,” said Pouria Sanae, ixlayer’s Chief Executive Officer and co-founder. “Dr. Esquival’s experience and clinical lens will be critical as we continue to expand our solutions and elevate industry best practices, and we’re thrilled to have him join our team.”

A healthcare industry veteran with more than a decade of experience driving innovations in the healthcare space, Esquivel has deep knowledge and experience in various domains, from genomics and precision medicine to population health management and digital health. His career has been laser focused on making precision medicine and digital health a reality, overcoming challenges to make it clinically actionable and cost-effective.

“The healthcare industry continues to evolve and today’s focus is very much around value-based care driven by population and individual outcomes -- centering the patient and their individual health data more than ever,” said Dr. Esquivel. “This is an exciting time to join the team at ixlayer and I look forward to helping foster innovation and growth in 2023 and beyond.”

ixlayer powers diagnostics and screening programs for organizations including health plans, retail, providers, biopharma and government, that seek more accessible methods for providing preventive care to members and patients. By offering turnkey programs, through a white labeled solution to drive member engagement, ixlayer helps its partners provide high-quality health care that enables members and patients to take control of their health - through early detection, prevention, and condition management.

About ixlayer
ixlayer is redefining next generation patient experiences for lab testing and better health outcomes. We make it easy for people to test outside of clinical settings and take proactive steps towards better health. We partner with payors, retail pharmacies, direct-to-consumer brands, biopharma, health systems, and telehealth providers to create configurable solutions for their patients, all under their own brand. ixlayer’s platform enables patient-friendly digital experiences, 1000s of testing options and seamless integration with our customers and lab partners. ixlayer is the infrastructure for millions of diagnostic tests for partners including the United States Coast Guard, Stanford Health, Salesforce, and multiple national health plans. Learn more at https://ixlayer.com/

Contacts

Press Inquiries:
Laura Vinci
Finn Partners on behalf of ixlayer
laura.vinci@finnpartners.com
212-593-5807

ixlayer


Release Versions

Contacts

Press Inquiries:
Laura Vinci
Finn Partners on behalf of ixlayer
laura.vinci@finnpartners.com
212-593-5807

More News From ixlayer

ixlayer Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, a leading digital platform for healthcare innovation services, today announced the ixlayer platform residing at Amazon Web Services (AWS) has earned certified status by HITRUST for information security. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization’s platform has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places ixlayer in an elite group...

ixlayer Partners With Porter to Close Care Gaps and Improve Patient Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announced a partnership with Porter, a leading care coordination company, to integrate ixlayer’s at-home testing and remote patient monitoring capabilities into Porter’s existing care coordination offerings. ixlayer will serve as the backbone of Porter’s infrastructure, enabling increased touchpoints during patient transitions from hospital to home, which will improve patient outcomes. “By joining forces wit...

ixlayer Prediabetes and Type 2 Diabetes Screening Tests Enable Retailers, Health Systems and Payers to Engage Early and More Frequently in Disease Prevention

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announced it will offer prediabetes and Type 2 diabetes screening tests to retail, health system and payer customers, underscoring the essential role of early screening and regular testing in preventing and managing these diseases. A new white paper highlights the significant prevalence of prediabetes and diabetes in the United States, and why regular testing is important to public health. “While there are r...
Back to Newsroom